MLICM
NAGE

Metropolitan Life Insurance Company (MetLife)’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,355
Closed -$33.6K – 2840
2021
Q3 		$33.6K Sell
5,355
-7,415
-58% -$46.5K ﹤0.01% 2797
2021
Q2 		$126K Buy
12,770
+1,604
+14% +$15.8K ﹤0.01% 2470
2021
Q1 		$104K Buy
+11,166
New +$104K ﹤0.01% 2411